Effect of interferon-alpha on soluble interleukin-2 receptor and tumor necrosis factor increase during immunotherapy with interleukin-2.
Lissoni
P
P
Ardizzoia
A
A
Rovelli
F
F
Perego
M
M
Cardellini
P
P
Tancini
G
G
Barni
S
S
D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood / Q000276:immunology; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage*; D007376:Interleukin-2 / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000097:blood / Q000276:immunology / Q000628:therapy*; D015375:Receptors, Interleukin-2 / Q000378:metabolism; D012995:Solubility; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D014408:Biomarkers, Tumor; D016898:Interferon-alpha; D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha